No Data
No Data
Wells Fargo Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $350
Wells Fargo analyst Tiago Fauth maintains $United Therapeutics(UTHR.US)$ with a buy rating, and maintains the target price at $350.According to TipRanks data, the analyst has a success rate of 38.8%
Wells Fargo Sticks to Its Buy Rating for United Therapeutics (UTHR)
Leerink Partners Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $344
Leerink Partners analyst Roanna Ruiz maintains $United Therapeutics(UTHR.US)$ with a buy rating, and adjusts the target price from $338 to $344.According to TipRanks data, the analyst has a success
United Therapeutics Insider Sold Shares Worth $2,355,544, According to a Recent SEC Filing
Martine A Rothblatt, Director, Chairperson & CEO, on July 15, 2024, sold 7,200 shares in United Therapeutics (UTHR) for $2,355,544. Following the Form 4 filing with the SEC, Rothblatt has control
Why United Therapeutics (UTHR) Is a Top Growth Stock for the Long-Term
Growth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company.
Express News | United Therapeutics Corp : Leerink Partners Raises Target Price to $344 From $338
No Data
151652693 : There are many theories that do not touch the QE factor that caused the rise and harvest of global finance
151336027 :![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
151830249 :![+1 👍](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f44d.png)
151078437 :![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
151817588 :![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
View more comments...